BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  New Triple Quadrupole Mass Spectrometer Brings Speed and High Performance to Routine Laboratories

  Analytical scientists facing the challenges of quantitation in food and environmental applications can now achieve high productivity and meet laboratory demands with a fast yet robust mass spectrometer.

  June 4, 2018

   · 

  3 min read
• Drug Development

  Eiger Announces HDV Phase 2 Program Oral Presentation and Investigator / Key Opinion Leader Reception for Planned HDV Phase 3 D-LIVR Study at Global Hepatitis Summit 2018™

  Eiger BioPharmaceuticals, Inc. announced that an oral presentation from the Phase 2 LOWR HDV (LOnafarnib With Ritonavir in Hepatitis Delta Virus) Program as well as an update on the Phase 3 D-LIVR study will be presented at Global Hepatitis Summit 2018™.

  June 4, 2018

   · 

  6 min read
• Business

  AOBiome Therapeutics Announces Election of Dr. Jun Wang as Chairman of the Board of Directors

  AOBiome Therapeutics announced the election of Jun Wang, Ph.D., founder and CEO of iCarbonX, as Chairman of AOBiome’s Board of Directors, effective May 31, 2018.

  June 4, 2018

   · 

  3 min read
• Biotech Beach

  Laboratory for Advanced Medicine to Present at 2018 BIO International Convention

  Laboratory for Advanced Medicine (LAM) announced that Justin Li, General Manager and Vice President of Finance, will present at the 2018 BIO International Convention.

  June 4, 2018

   · 

  3 min read
• Pharm Country

  The Jed Foundation Hosts 17th Annual Gala

  The Jed Foundation (JED) will host their 17th Annual Gala tonight, Monday June 4th at Cipriani Wall Street.

  June 4, 2018

   · 

  2 min read
• Drug Development

  Daiichi Sankyo Presents Phase 3 ENLIVEN Study of Pexidartinib, Demonstrating Statistically Significant Clinical Improvement Across Multiple Endpoints at 2018 American Society of Clinical Oncology (ASCO) Annual

  Daiichi Sankyo Company, Limited announced that the phase 3 ENLIVEN study showed a statistically significant 39 percent overall response rate (ORR) at week 25 based upon central review of MRI scans using Response Evaluation Criteria in Solid Tumors.

  June 4, 2018

   · 

  8 min read
• BioMidwest

  ViewRay® to Present at the Jefferies 2018 Global Healthcare Conference

  ViewRay, Inc. announced that James F. Dempsey, PhD, Founder and Chief Scientific Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to present at the Jefferies 2018 Global Healthcare Conference.

  June 4, 2018

   · 

  1 min read
• Drug Development

  MEI Pharma Presents Phase 1b Clinical Data for ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

  90% Objective Response Rate Observed in Patients with Indolent B-Cell Malignancies

  June 4, 2018

   · 

  8 min read
• Policy

  BioMarker Strategies Announces Chinese Patent for PathMAP Functional Signaling Profile Technology

  BioMarker Strategies, LLC, announced that the Chinese Patent Office has granted a patent covering the Company’s PathMAP® Functional Signaling Profile technology.

  June 4, 2018

   · 

  4 min read
• Policy

  Cogstate Announces European Approval for Healthcare Offering

  Cogstate announced that its Healthcare Division has received CE Mark approval for its CognigramTM digital cognitive assessment system.

  June 4, 2018

   · 

  1 min read